Fecal calprotectin is already an established biomarker for inflammatory bowel disease. But because conventional calprotectin is measured in fecal samples there is low patient compliance and high day-to-day variance resulting in low precision and accuracy.

Watch Joachim present our exciting biomarker data from Nordic Bioscience’s novel serum calprotectin assay for inflammatory bowel disease.

Learn more

Please don't hesitate to contact us if you have any questions or other inquiries.

Are you interested in learning more about Nordic Bioscience?
Enter your information in the form and a representative will contact you shortly.

By submitting this form you agree to our terms and conditions.